We recommend that you upgrade to the latest version of your browser.
A person holding a device

Conduct clinical studies in the oncology department.

We conduct more than 29,000 outpatient consultations each year. Participation in clinical studies is considered for all our patients.

Information for patients and relatives

Clinical Trials for All Our Patients

The oncology department is continuously working to offer clinical trials to all patient groups receiving treatment with us.

We treat patients with:

  • Bladder, prostate, or kidney cancer
  • Oesophageal, gastric, small intestine, or large intestine cancer
  • Breast cancer
  • Skin cancer (malignant melanoma)

Talk to us about clinical trials at: ClinicalTrials.Oncology@ahus.no

How We Make It Possible

The oncology department has dedicated examination and consultation rooms for patient visits in clinical studies. We have dedicated laboratory facilities for processing samples that are to be sent to central laboratories. The department has around 15 full-time equivalents who exclusively work on the execution of clinical studies.

All doctors affiliated with the department are certified in Good Clinical Practice (GCP) and are available as investigators in clinical studies.

The oncology department is responsible for approximately 627,000 residents, equivalent to 10 per cent of Norway's population. We conduct more than 29,000 outpatient consultations each year.

Map
Map of the catchment area and locations for the oncology department at Ahus.

Weekly multidisciplinary treatment meetings ensure that all suitable patients are offered the opportunity to participate in one of the ongoing clinical studies in the oncology department.

Oncology Ward

Our patients are prioritised to their own ward, which simplifies classification, treatment, and reporting of Serious Adverse Events (SAE) and enables phase I clinical studies.

Radiology Department

We have specific agreements with the radiology department that performs both diagnostic and interventional procedures. We can provide protocol-adapted nuclear medicine, CT, MRI, X-ray, and ultrasound examinations.

Laboratory Medicine and Biochemistry

Ahus interdisciplinary laboratory medicine and medical biochemistry (TLMB) conducts laboratory investigations within the fields of medical biochemistry, pharmacology, medical immunology, allergology, and infectious immunology. The laboratories are accredited according to the NS-EN ISO/IEC 15189 standard.

Department of Pathology

The pathology department performs cytological, histological, and molecular genetic diagnostic procedures and is accredited according to the NS-EN ISO/IEC 15189 standard.

Read more about how we conduct clinical trials in the timeline at the bottom of this page.

Collaborate with us

We are always looking for new collaborations and partners.

If you wish to conduct a feasibility study or have other enquiries, you can send us an email.

We normally respond within five working days.

ClinicalTrials.Oncology@ahus.no
A doctor and a patient

Clinical studies from request to archive

Feasibility

We receive inquiries about new clinical trials via email: ClinicalTrials.Oncology@ahus.no

Requests are typically answered within five business days.

Site Validation and Selection

We are committed to ensuring timely and well-coordinated validation visits.

Regulatory approvals

We can assist in preparing key documents such as the patient information and consent forms. To simplify the process, the Norwegian authorities have developed templates that meet national regulatory requirements: Templates – Rekportalen.

Once the regulatory applications have been submitted, our Data Protection Officer can begin reviewing the clinical trial in a parallel process.

Budget and contracts

All clinical trials initiated by the pharmaceutical industry must be reported to Inven2, which acts as a third party in negotiations regarding budgets, contracts, and payments related to clinical trials within the health region to which Ahus belongs.

For more information, visit: Industry Information – Inven2

Academic studies generally do not need to be reported to Inven2. Please contact us if you are unsure whether your study should be registered.

Site Initiation and Activation

We facilitate close communication between the Study Site and the Sponsor to ensure activation is achieved as quickly as possible. Typically, all key personnel will participate in the study initiation visit.

Recruitment and follow-up

We work as efficiently as possible to reach the assigned number of patients included in each clinical trial. Financial follow-up is conducted twice a year (March and October) via Inven2 for clinical trials commissioned by the pharmaceutical industry.

For more information, visit: Industry Information – Inven2

Academic studies that are not registered with Inven2 are followed up financially according to project-specific agreements.

Study closure and archiving

Our continuous monitoring of electronic data capture systems, including ongoing data entry and resolution of queries and comments, contributes to an efficient closure of the clinical trial.

The Investigator Site File (ISF) is maintained and updated throughout the course of the study and, upon study completion, is prepared for long-term archiving in accordance with applicable regulations.

Last updated 9/2/2025